InMode (INMD) Stock Price, News & Analysis

Company Overview

InMode Ltd. (NASDAQ:INMD) is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.

InMode’s product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.

The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America. In addition to product deployment, InMode provides training, clinical support and marketing services to practitioners to facilitate the adoption of its platforms.

Founded in the late 2000s, InMode completed its initial public offering in 2019. Managed by an experienced leadership team with backgrounds in medical device development, its ongoing research and development efforts focus on expanding its aesthetic treatment portfolio and exploring new clinical applications of its energy-based platforms.

Key Stats

• Today's Range: $14.98 to $15.61
• 50-Day Range: $13.66 to $15.46
• 52-Week Range: $13.14 to $19.85
• Volume: 1.00 million shs
• Average Volume: 760,464 shs
• Market Capitalization: $957.63 million
• P/E Ratio: 6.13
• Dividend Yield: N/A
• Price Target: $18.04
• Consensus Rating: Hold

InMode Stock Analysis - MarketRank™

InMode scored higher than 62% of companies evaluated by MarketBeat, and ranked 399th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Hold

Consensus Rating

InMode has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 8 hold ratings, and 1 sell rating.

Upside Potential

InMode has a consensus price target of $18.04, representing about 19.1% upside from its current price of $15.15.

Amount of Analyst Coverage

InMode has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 4.00%

Earnings Growth

Earnings for InMode are expected to grow by 4.00% in the coming year, from $1.75 to $1.82 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of InMode is 6.13, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 232.13.

Price to Earnings Ratio vs. Sector

The P/E ratio of InMode is 6.13, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 86.96.

Price to Book Value per Share Ratio

InMode has a P/B Ratio of 1.50. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.55% of the outstanding shares of InMode have been sold short.

Short Interest Ratio / Days to Cover

InMode has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in InMode has recently increased by 1.74%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

InMode does not currently pay a dividend.

Dividend Growth

InMode does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

5.55% of the outstanding shares of InMode have been sold short.

Short Interest Ratio / Days to Cover

InMode has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in InMode has recently increased by 1.74%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.84

News Sentiment

InMode has a news sentiment score of 0.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for InMode this week, compared to 5 articles on an average week.

Search Interest

Only 1 people have searched for INMD on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

3 people have added InMode to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, InMode insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 6.92% of the stock of InMode is held by insiders.

Percentage Held by Institutions

68.04% of the stock of InMode is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

INMD Stock Analysis - Frequently Asked Questions

How have INMD shares performed this year?

InMode's stock was trading at $16.70 at the beginning of 2025. Since then, INMD stock has decreased by 9.3% and is now trading at $15.15.

How were InMode's earnings last quarter?

InMode Ltd. (NASDAQ:INMD) released its earnings results on Wednesday, July, 30th. The healthcare company reported $0.47 earnings per share for the quarter, missing analysts' consensus estimates of $0.50 by $0.03. The business's revenue for the quarter was up 10.6% on a year-over-year basis.
Read the conference call transcript.

When did InMode's stock split?

Shares of InMode split before market open on Thursday, September 30th 2021.The 2-1 split was announced on Friday, September 17th 2021. The newly created shares were distributed to shareholders after the closing bell on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Does InMode have any subsidiaries?

InMode subsidiaries include these companies: Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd..

When did InMode IPO?

InMode (INMD) raised $75 million in an initial public offering on Thursday, August 8th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. ​Barclays, UBS Investment Bank and Canaccord Genuity acted as the underwriters for the IPO and Baird was co-manager.

How do I buy shares of InMode?

Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of InMode own?

Based on aggregate information from My MarketBeat watchlists, some other companies that InMode investors own include Symbotic (SYM), JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Voya Infrastructure, Industrials and Materials Fund (IDE), Voyager Therapeutics (VYGR), Humana (HUM), American Water Works (AWK) and Waste Connections (WCN).

Company Calendar

• Last Earnings: 7/30/2025
• Today: 10/05/2025
• Next Earnings (Estimated): 10/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:INMD
• CIK: 1742692
• Web: www.inmodemd.com
• Phone: 972-4909-7470
• Fax: N/A
• Employees: 480
• Year Founded: 2008

Price Target and Rating

• Average Price Target for InMode: $18.04
• High Price Target: $25.00
• Low Price Target: $15.00
• Potential Upside/Downside: +19.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 10 Analysts

Profitability

• EPS (Trailing Twelve Months): $2.47
• Trailing P/E Ratio: 6.13
• Forward P/E Ratio: 8.66
• P/E Growth: N/A
• Net Income: $181.27 million
• Net Margins: 44.50%
• Pretax Margin: 35.81%
• Return on Equity: 18.38%
• Return on Assets: 16.35%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 9.60
• Quick Ratio: 8.58

Sales & Book Value

• Annual Sales: $394.82 million
• Price / Sales: 2.43
• Cash Flow: $1.82 per share
• Price / Cash Flow: 8.31
• Book Value: $10.12 per share
• Price / Book: 1.50

Miscellaneous

• Outstanding Shares: 63,210,000
• Free Float: 58,835,000
• Market Cap: $957.63 million
• Optionable: Optionable
• Beta: 2.09